BeOne Medicines AG (HKG:6160)

BeOne Medicines AG Revenue

BeOne Medicines AG had revenue of 1.51B CNY in the quarter ending March 31, 2026, with 35.46% growth. This brings the company's revenue in the last twelve months to 5.74B, up 37.44% year-over-year. In the year 2025, BeOne Medicines AG had annual revenue of 5.34B with 40.23% growth.

• Revenue (ttm): 5.74B CNY
• Revenue Growth: +37.44%
• P/S Ratio: 5.26
• Revenue / Employee: 478.27K CNY
• Employees: 12,000
• Market Cap: 235.39B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.34B	1.53B	40.23%
Dec 31, 2024	3.81B	1.35B	54.96%
Dec 31, 2023	2.46B	1.04B	73.65%
Dec 31, 2022	1.42B	239.64M	20.37%
Dec 31, 2021	1.18B	867.41M	280.83%
Dec 31, 2020	308.87M	-119.34M	-27.87%
Dec 31, 2019	428.21M	229.99M	116.03%
Dec 31, 2018	198.22M	-40.17M	-16.85%
Dec 31, 2017	238.39M	237.32M	22,179.16%
Dec 31, 2016	1.07M	-7.75M	-87.86%
Dec 31, 2015	8.82M	-4.22M	-32.37%
Dec 31, 2014	13.04M	1.89M	16.93%
Dec 31, 2013	11.15M	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error